Biowa, Inc
BioWa is a U.S. subsidiary of Kyowa Kirin and the exclusive worldwide licensor of Potelligent® Technology, a proprietary technology that creates 100% fucose-free monoclonal antibodies that demonstrate a marked increase in antibody-dependent cellular cytotoxicity (ADCC). A critical function of the immune system, ADCC enhances the ability of antibodies to kill tumor cells. With BioWa’s technology, enhancement of monoclonal antibody (Mab) potency has been shown to increase up to 100 fold both in vitro and in vivo.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
5
tools in use
Monthly traffic
6.8K
organic / mo
Sign up free to see all 8 verified contacts at Biowa, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- NM
Nehal Mohamed
Director, R & d Operations · General Business & Management
EmailPhone - AV
Achilles V.
, - · Other
EmailPhone - SF
Sarah Fuller
, - · Other
EmailPhone
Showing 3 of 8 verified contacts
Top roles at Biowa, Inc
7 distinct titles indexed · top 7 shown.
- 2, -
- 1cfo
- 1clinical trial manager
- 1director, r & d operations
- 1legal administration
- 1manager, business development
- 1member of bord of directors
Sign up to unlock all 8 contacts at Biowa, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Biowa, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.